Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
lanthanum carbonate
|
| gptkbp:approvalYear |
2004
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
V03AE03
|
| gptkbp:contraindication |
gptkb:bowel_obstruction
hypophosphatemia |
| gptkbp:form |
chewable tablet
|
| gptkbp:genericName |
lanthanum carbonate
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fosrenol
|
| gptkbp:indication |
chronic kidney disease
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Shire_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
phosphate binder
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting abdominal pain constipation |
| gptkbp:usedFor |
hyperphosphatemia
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|